VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Us2.ai has a feature that leverages the speed of our AI,

<< Previous

Bullboard Posts

Next >>

Comment by jopatcloon Nov 11, 2024 3:50pm

44 Views

Post# 36307154

RE:RE:Us2.ai has a feature that leverages the speed of our AI,

Proud to announce that Queen Elizabeth Hospital (QEH) in Hong Kong has become the first public hospital in the region to integrate Us2.ai's AI technology into their echocardiography department. This milestone highlights the hospital's commitment to advancing clinical operations and enhancing patient care with cutting-edge AI solutions.

A special thank you to Dr. Michael Lee, Dr. Eric Wong, and Ms. Cecilia Chan for their invaluable support in launching this pilot project.

This collaboration represents a pivotal step in integrating AI into healthcare systems, leveraging Us2.ai’s technology to improve diagnostic accuracy, accelerate decision-making, and enable more personalised patient care. By adopting AI-driven solutions, QEH is setting new standards for patient outcomes and solidifying its position at the forefront of medical innovation.

HealthcareInnovation AIinHealthcare PatientCare Us2AI QueenElizabethHospital Cardiology Ultrasound Echocardiogram AI